DSwiss Inc (DQWS) stock: key figures, P/E, revenue and dividend

Materials · Malaysia

Price
0.08 USD
Market cap
17.38 m USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–

DSwiss Inc financials

Fiscal year2025
Revenue2.92 m USD
Gross profit564,562.00 USD
Operating income-1,167.00 USD
EBIT-60,888.00 USD
Net income-76,860.00 USD
Diluted EPS – continuing operations-0.00 USD

Full history since 2014, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About DSwiss Inc

DSwiss, Inc., a biotech nutraceutical company, provides healthcare, skincare, and personal care products in Malaysia, Singapore, Indonesia, Australia, Hong Kong, Taiwan, Macau, and China. It supplies health and beauty products, including weight management beverages, anti-aging creams, and immune system enhancers. The company also provides private label manufacturing services for nutraceutical and skincare/personal care ODM/OEM products; pet wellness supplements; and pet-care products, as well as medical consumable supplies, such as disposable stretcher cover and bedsheet, masks, body infrared thermometers, sanitizer, protective goggles, surgical gloves, isolation suit, industrial disinfectant, and protection surgical and medical gown. In addition, it offers OEM/ODM/OBM services, such as DSwiss quantum magnetic analyzer and DNA genotyping services; Eyecare; and biotechnology research channel services. DSwiss, Inc. was incorporated in 2015 and is headquartered in Kuala Lumpur, Malaysia.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.